Home
>
National Drug Code (NDC)
>
La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes
La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes - 66382-157-01 - (Octinoxate Titanium dioxide)
Drug Information of La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes
| Product NDC: | 66382-157 |
| Proprietary Name: | La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes |
| Non Proprietary Name: | Octinoxate Titanium dioxide |
| Active Ingredient(s): | 1.125; 1.14 mL/15mL; mL/15mL & nbsp; Octinoxate Titanium dioxide |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes
| Product NDC: | 66382-157 |
| Labeler Name: | Laboratoires Industriels de Vichy (LIDV) |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20090901 |
Package Information of La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes
| Package NDC: | 66382-157-01 |
| Package Description: | 1 TUBE in 1 CARTON (66382-157-01) > 15 mL in 1 TUBE |
NDC Information of La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes
| NDC Code | 66382-157-01 |
| Proprietary Name | La Roche-Posay Laboratoire Pharmacetique HydraPhase UV Eyes |
| Package Description | 1 TUBE in 1 CARTON (66382-157-01) > 15 mL in 1 TUBE |
| Product NDC | 66382-157 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Octinoxate Titanium dioxide |
| Dosage Form Name | LOTION |
| Route Name | TOPICAL |
| Start Marketing Date | 20090901 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | Laboratoires Industriels de Vichy (LIDV) |
| Substance Name | OCTINOXATE; TITANIUM DIOXIDE |
| Strength Number | 1.125; 1.14 |
| Strength Unit | mL/15mL; mL/15mL |
| Pharmaceutical Classes |
